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Supplementary Fig. 3 . Distribution of daily activity in chronic Air, CS, Air+Virus and CS+Virus exposed mice. Data from chronic (6 months) air-or CS-exposed mice given intranasal inoculation of either saline (control group) or influenza A virus (IAV; treatment group) at ZT4-6 are shown. Locomotor activity data were recorded from day 1-9 post-infection.
Data are plotted as percentage of daily activity as a function of photoperiod (12h light phase; open circles, 12h dark phase; closed circles). (a) Chronic air-exposed mice were primarily active (70-80% activity) during the dark phase and less active (20-30%) during the light phase from day 2-9 post-saline infusion. (b) Chronic CS-exposed mice showed overall greater activity (70-80%) during the dark phase, with the exception being a transient inversion of this relationship on day 3 of recording similar to air-exposed mice. (c) Chronic air-exposed mice infected with IAV were primarily active (70-80% activity) during the dark phase and less active (20-30%) during the light phase from day 2-9 post-infection similar to air-exposed mice. (d) As in air-exposed mice, IAV infection of chronic CS-exposed mice transiently reduced nighttime activity and increased 7 daytime activity on day 1 post-infection. By day 2, this response was reversed but the level of nighttime activity gradually declined in parallel with a slight increase in daytime activity over the next 4-5 days after infection such that a near 50/50 split was reached by day 7. By day 8-9 postinfection the CS+Virus group appeared to recover their normal nighttime (70-80%) and daytime (20-30%) activity levels, most likely due to mortality among mice with a more even distribution of activity. Data are mean ± SEM (n=6 mice/group). *P < 0.05; **P < 0.01; ***P < 0.001 significant compared to respective light phase in each treatment groups. primarily (70-80% activity) active during the dark phase both prior to and after saline infusion.
(b)
In contrast with WT mice, uninfected BMAL1 KO mice displayed a near even distribution of activity across the light-dark cycle that was not affected by saline infusion. This distribution is due to behavioral arrhythmia in these mice (c) IAV infection significantly reduced the level of nighttime activity and increased daytime activity in WT mice, resulting in a near even distribution of activity across the 24h day. (d) IAV infection further enhanced the amount of daytime activity and reduced the level of nighttime activity in BMAL1 KO mice, an effect also 9 associated with near complete arrhythmicity. Data are representative of mean ± SEM (n=10 WTSaline; n=4 BMAL1 KO-Saline; n=13 WT-Virus; n= 13 BMAL1 KO-Virus). In both A and B the day of IAV or saline infusion is indicated by a red arrowhead. *P < 0.05; **P < 0.01; ***P < 0.001 significant compared to corresponding light phase in each treatment group. CS; n= 4-7 Air+Virus and n=4-7 CS+Virus) for each time point (ZT6/12 and ZT18/24). * P < 0.05; ** P < 0.01; *** P < 0.001, significant compared to air or Air+Virus; $ P < 0.05 significant compared to air-exposed mice; # # # P < 0.001 significant compared to CS-exposed mice. Tables   Supplementary Table 1 . Lung compliance measured during different day and night ZT time in chronic air-and CS-exposed mice infected with influenza A virus 
------------------------------------------------------------------------------------------------------------------------

Day / Night Compliance (mL/cmH 2 O) ZT (h) --------------------------------------------------------------------------------------------------------
Air ‡ CS ‡
Air + Virus CS + Virus -----------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------
Data are shown as mean ± SEM (n=4-6 per group). § P < 0.01, significant compared to air (ZT6 + ZT24); ** P < 0.01, significant compared to air + virus (ZT12 + ZT18); # # P < 0.01, and $ $ P < 0.01, significant compared to CS + virus (ZT12 + ZT18). ‡ Data from animals exposed to air/CS for 6 months from a previous study were included here for comparison 30 .
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Data are shown as mean ± SEM (n=4-6 per group). § P < 0.05, and § P < 0.01, significant compared to air (ZT12 + ZT18) and (ZT6 +ZT24) respectively; $ P < 0.05, and ***P < 0.001, significant compared to air + virus (ZT6 + ZT24) and (ZT12 + ZT18), respectively; # # # P < 0.001, and $ $ $ P < 0.01, significant compared to CS + virus (ZT12 + ZT18); † P < 0.01, significant compared to CS + virus (ZT12 + ZT18). ‡ Data from animals exposed to air/CS for 6 months from a previous study were included here for comparison 30 . --------------------------------------------------------------------------------------------------------------------- 
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ZT (h) ------------------------------------------------------------------------------------------------------
Air ‡ CS ‡ Air + Virus CS + Virus ------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------
Data are shown as mean ± SEM (n=4-6 per group). § P < 0.05, § P < 0.01, significant compared to air (ZT12 + ZT18) and (ZT6 +ZT24); *** P < 0.001, significant compared to air + virus (ZT12 + ZT18); # # P < 0.01, and $ $ P < 0.01, significant compared to CS + virus (ZT12 + ZT18). ‡ Data from animals exposed to air/CS for 6 months from a previous study were included here for comparison 30 .
